100% tariff on drugs, markets, Sensex slipped more than 700 points, these shares are bad

By Khanderao Deshmukh

Published on:


Stock Market Today: After the announcement of US President Donald Trump to impose 100 percent tariff on medicines from next month, there was tremendous pressure on the Indian market. Pharma and IT shares were sold on fast on Friday. The 30 -point Sensex on BSE, where 733 points fell 0.90 percent to close at the lowest level of three weeks. Whereas, the Nifty 50 on NSE also fell 236.15 points or 0.95 percent to 24,654.70 points. This was the sixth consecutive session when the last trading day of the week declined.

Shares of pharmaceutical companies rolled

After the US President’s decision to apply 100% tariffs on the drugs from October 1, the stocks of most pharma companies declined. While the BSE Healthcare Index fell down 2.14%, while the stocks’ shares saw a big decline of 9.4%.

Among the companies in the Group of Sensex, Mahindra & Mahindra, Mahindra, Tata Steel, Bajaj Finance, Asian Paints, Sun Pharma, Tech Mahindra, Infosys, Tata Consultancy Services and HCL Tech saw the biggest decline. At the same time, the shares of Larsen & Toubro, Tata Motors, ITC and Reliance Industries saw a boom trend.

What do market experts say?

Online Business and Property Technology firm Enrich Money CEO Ponmudi R. Says that the trump administration was a huge decline due to widespread selling in Indian stock markets after the trump administration announced to impose 100% tariffs on imports of branded and patent drugs. This unexpected step worked to further spoil the perception of weak investors already. After the recent decision to increase the H-1B visa fee, there was a huge selling in IT stocks.

Also read: India ready to stop import of crude oil from Russia, but this big condition put in front of America

Disclaimer: (The information provided here is being given only for information. It is necessary to tell here that the investment in the market is subject to risks. Always consult expert before investing as an investor. Abplive.com is never advised to invest money here.)

Khanderao Deshmukh

Khanderao Deshmukh aims to guide job seekers by delivering accurate, timely, and easy-to-understand information, helping them secure stable government careers.

Related Post

State Govt Jobs vs Central Govt Jobs 2026 – Which is Better?

State Govt Jobs vs Central Govt Jobs 2026: Many aspirants preparing for government exams often get confused between State Government Jobs and Central Government Jobs. Both ...

UPSC Government Job Vacancy Recruitment 2026 – Complete Guide to Officer, Scientist & Faculty Posts

The UPSC Government Job Vacancy Recruitment 2026 brings an exceptional opportunity for aspirants seeking prestigious Group-A and Group-B government jobs across India. Conducted by the Union ...

NIC Various Scientist Vacancy Recruitment 2026—Complete Guide to Apply for Scientist B, C & D Posts

The NIC Various Scientist Vacancy Recruitment 2026 presents a remarkable opportunity for aspiring engineers and experienced professionals to secure prestigious Group-A government positions in India’s leading ...

Documents Required for Government JobVerification 2026 (Complete List)

Documents Required for Government JobVerification 2026: After clearing a government exam, the next important step is document verification. Many candidates face rejection at this stage due ...

Leave a Comment